Browse
Submit Data
Databases
API
Help

Dataset Information

26 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses.

ABSTRACT:

SUBMITTER: Zhu Y

PROVIDER: S-EPMC8330190 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Similar Datasets

High-Throughput Screening and Identification of Potent Broad-Spectrum Inhibitors of Coronaviruses.

Project description: Not available

| S-EPMC6613765 | biostudies-literature

B7-H3-Targeted CAR-Vδ1T Cells Exhibit Potent Broad-Spectrum Activity Against Solid Tumors

Project description:Vδ1T cells, a rare subset of γδT cells, hold promise for treating solid tumors. Unlike conventional T cells, they recognize tumor antigens independently of the MHC antigen-presentation pathway, making them a potential “off-the-shelf” cell therapy product. However, isolation and activation of Vδ1T cells is challenging, which has limited their clinical investigation. Here, we developed a large-scale clinical-grade manufacturing process for Vδ1T cells and validated the therapeutic potential of B7-H3-CAR-modified Vδ1T cells in treating solid tumors. Co-expression of interleukin-2 with the B7-H3-CAR led to durable anti-tumor activity of Vδ1T cells in vitro and in vivo. In multiple subcutaneous and orthotopic mouse xenograft tumor models, a single intravenous administration of the CAR-Vδ1T cells resulted in complete tumor regression. These modified cells demonstrated significant in vivo expansion and robust homing ability to tumors, akin to natural tissue-resident immune cells.Additionally, the B7-H3-CAR-Vδ1T cells exhibited a favorable safety profile. In conclusion, B7-H3-CAR-modified Vδ1T cells represent a promising strategy for treating solid tumors.

2024-08-22 | GSE275242 | GEO

Structural basis of potent and broad HIV-1 fusion inhibitor CP32M.

Project description: Not available

| S-EPMC3411002 | biostudies-literature

A broad-spectrum and highly potent human monoclonal antibody cocktail for rabies prophylaxis.

Project description: Not available

| S-EPMC8409651 | biostudies-literature

Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection.

Project description: Not available

| S-EPMC1426979 | biostudies-literature

Rational design of highly potent broad-spectrum enterovirus inhibitors targeting the nonstructural protein 2C.

Project description: Not available